Announced Thu, 24 Sept, 2026 · 15:27 IST
NSE rejects waiver; Gufic to pay Rs 1.72 lakh penalty by Oct 3
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.6%1-day move
₹437.95
prior close
₹425.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.6-3.7-0.3-1.9-4.0-2.2————
Up moveDown movePending
AI summary
NSE has rejected Gufic Biosciences' waiver application for a Rs 1.72 lakh penalty (excluding GST) levied for the September 2024 quarter. The penalty relates to non-compliance with SEBI's Regulation 17(1A) regarding appointment of Mr. Kamal Kishore Seth (age 75+) as Non-Executive Independent Director without a shareholders' special resolution. BSE had also rejected its waiver earlier in March 2026. The company will pay the NSE penalty by October 3, 2026.
Likely market impact
Minor financial impact; penalty is small relative to company size but flags a governance compliance gap on director appointment norms.